Ticker
FATECompany Name
FATE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 107.95M | $ 0 | $ 0 | $ 0 | 0% |
3/31/2025 | $ 114.63M | $ -666K | $ 0 | $ 0 | 0.58% |
12/31/2024 | $ 103.71M | $ 74.83M | $ 0 | $ 0 | -72.15% |
9/30/2024 | $ 271.07M | $ 74.65M | $ 0 | $ 0 | -27.54% |
6/30/2024 | $ 380.35M | $ 74.65M | $ 0 | $ 0 | -19.63% |
3/31/2024 | $ 443.94M | $ 75.37M | $ 0 | $ 0 | -16.98% |
12/31/2023 | $ 689.7M | $ 85K | $ 0 | $ 0 | -0.01% |
9/30/2023 | $ 229.74M | $ 1.78M | $ 0 | $ 0 | -0.78% |
6/30/2023 | $ 347.93M | $ 3.27M | $ 0 | $ 0 | -0.94% |
3/31/2023 | $ 621.79M | $ 6.62M | $ 0 | $ 0 | -1.06% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for FATE THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 277.76M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -14M ]) / Market Cap [ $ 4.36B ]
(=) Shareholder Yield [ -6.06% ]
Minimum
Dec 31, 2024
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.12% |